Načítá se...
72 Use of Palivizumab in Canada; Data from the CARESS registry 2005–2017
BACKGROUND: The Canadian Registry of Palivizumab (CARESS) tracks palivizumab utilization and hospitalizations for respiratory illness (RI) and respiratory syncytial virus (RSVH) in high-risk infants, whatever the indication. The decision to administer palivizumab is taken by individual clinicians at...
Uloženo v:
| Vydáno v: | Paediatr Child Health |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543371/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pch/pxz066.071 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|